Glucagonoma Active Not Recruiting Phase 2 Trials for Regorafenib (DB08896)

Also known as: Glucagonomas

IndicationStatusPhase
DBCOND0000819 (Glucagonoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02259725Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsTreatment